Literature DB >> 22679045

Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir.

Partha Das1, Vadamalai Vivek, Martin Ford, Edward Kingdon, Stephen Holt.   

Abstract

Membranous glomerulonephritis is the most common histological renal lesion associated with hepatitis B virus (HBV) infection. The authors describe here a case of a patient presenting with the nephrotic syndrome and HBV infection but without progressive liver disease. The use of lamivudine and tenofovir resulted in arrest of proteinuria and stabilisation of renal function.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22679045      PMCID： PMC3176360          DOI： 10.1136/bcr.05.2011.4287

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  14 in total

1.  Tenofovir in chronic hepatitis B.

Authors:  P Del Poggio; C Jamoletti; M Zaccanelli
Journal:  Hepatology       Date:  2005-05       Impact factor: 17.425

2.  Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.

Authors:  Joel E Gallant; Michelle A Parish; Jeanne C Keruly; Richard D Moore
Journal:  Clin Infect Dis       Date:  2005-03-17       Impact factor: 9.079

3.  Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane.

Authors:  B Combes; J Shorey; A Barrera; P Stastny; E H Eigenbrodt; A R Hull; N W Carter
Journal:  Lancet       Date:  1971-07-31       Impact factor: 79.321

4.  Role of interferon-alpha in the treatment of primary glomerulonephritis.

Authors:  J Al-Wakeel; A Mitwalli; N Tarif; S Al-Mohaya; G Malik; M Khalil
Journal:  Am J Kidney Dis       Date:  1999-06       Impact factor: 8.860

5.  Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection.

Authors:  Florian van Bömmel; Thomas Wünsche; Stefan Mauss; Petra Reinke; Alexandra Bergk; Dirk Schürmann; Bertram Wiedenmann; Thomas Berg
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

6.  Membranous nephropathy related to hepatitis B virus in adults.

Authors:  K N Lai; P K Li; S F Lui; T C Au; J S Tam; K L Tong; F M Lai
Journal:  N Engl J Med       Date:  1991-05-23       Impact factor: 91.245

7.  Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

Authors:  Patrick Marcellin; Ting-Tsung Chang; Seng Gee Lim; Myron J Tong; William Sievert; Mitchell L Shiffman; Lennox Jeffers; Zachary Goodman; Michael S Wulfsohn; Shelly Xiong; John Fry; Carol L Brosgart
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

8.  Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.

Authors:  K Chayama; Y Suzuki; M Kobayashi; M Kobayashi; A Tsubota; M Hashimoto; Y Miyano; H Koike; M Kobayashi; I Koida; Y Arase; S Saitoh; N Murashima; K Ikeda; H Kumada
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

9.  The clinical course of hepatitis B virus-associated nephropathy.

Authors:  R D Gilbert; J Wiggelinkhuizen
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

10.  Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon.

Authors:  C Y Lin
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612
View more
  3 in total

1.  Syphilis: a reversible cause of nephrotic syndrome.

Authors:  M Louis Handoko; Marjolijn Duijvestein; Cornelis G Scheepstra; Carola W H de Fijter
Journal:  BMJ Case Rep       Date:  2013-02-08

Review 2.  A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.

Authors:  Stephen G Holt; David M Gracey; Miriam T Levy; David W Mudge; Ashley B Irish; Rowan G Walker; Richard Baer; Jacob Sevastos; Riaz Abbas; Mark A Boyd
Journal:  AIDS Res Ther       Date:  2014-11-10       Impact factor: 2.250

3.  Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report.

Authors:  Chun Shan; Guo Qing Yin; Pei Wu
Journal:  J Med Case Rep       Date:  2014-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.